2021-11-15T13:44:11-06:00 2020-12-31 366055558 GRANT THORNTON LLP 1000 WILSON BLVD SUITE 1400 ARLINGTON VA 22209 990 2020-01-01 237311318 DRUG INFORMATION ASSOCIATION INC DRUG 2154426100 21 DUPONT CIRCLE NW SUITE 300 WASHINGTON DC 20036 VIVIANNA GUZMAN CFO 2154426100 2021-11-15 1 VIVIANNA GUZMAN 999009999 MARY TORRETTA P00847851 7038477500 3 AAL1 IAL1 2020 2022-09-23 18:48:47Z BARBARA LOPEZ KUNZ 21 DUPONT CIRCLE NW SUITE 300 WASHINGTON DC 20036 21866512 0 X WWW.DIAGLOBAL.ORG X 1964 MD SEE SCHEDULE O 12 12 54 2500 407496 4851 0 0 23618071 13634198 523966 271596 0 5000000 24142037 18905794 7759 220 0 0 10338897 9813726 0 0 0 13668531 9208908 24015187 19022854 126850 -117060 15523543 19738468 8385512 11860341 7138031 7878127 X SEE SCHEDULE O 0 0 9728208 220 956759 PROGRAM SERVICE ACCOMPLISHMENT 1DIA PROVIDES PROGRAMS TO DEVELOP, STRENGTHEN, AND SUPPORT COLLABORATION WITH POLICY MAKERS, INDUSTRY REPRESENTATIVES, PUBLIC HEALTH AUTHORITIES, ACADEMIA AND OTHER HEALTHCARE STAKEHOLDERS. 3776096 9102135 SEE SCHEDULE O 716182 3167808 SEE SCHEDULE O 46709 407496 PUBLICATIONS: THERAPEUTIC INNOVATION & REGULATORY SCIENCE PUBLICATION (TIRS) IS THE OFFICIAL JOURNAL OF DIA. ITS MISSION IS TO ADVANCE HEALTHCARE PRODUCT DISCOVERY, DEVELOPMENT, REGULATION, AND USE THROUGH THE PUBLICATION OF PEER-REVIEWED ARTICLES AND COMMENTARIES ACROSS THE SPECTRUM OF CONVERTING BIOMEDICAL SCIENCE INTO PRACTICAL SOLUTIONS TO ADVANCE HUMAN HEALTH. IT IS PUBLISHED IN ODD NUMBER MONTHS, JANUARY, MARCH, MAY, JULY, SEPTEMBER, AND NOVEMBER. DIA ALSO PUBLISHES THE GLOBAL FORUM, ANOTHER E-PUBLICATION. IT OFFERS EXPERT GLOBAL AND REGIONAL COVERAGE OF DISCOVERY, DEVELOPMENT, REGULATION, SURVEILLANCE, AND MARKETING OF HEALTHCARE PRODUCTS, INCLUDING INTERVIEWS WITH LEADERS AND TOPICAL SUMMARIES FROM EDUCATIONAL EVENTS. IT IS PUBLISHED MONTHLY. 46709 407496 14267195 1 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 1 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 0 0 1 54 1 1 1 1 CH IN JA SZ 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 1 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 X VIVIANNA GUZMAN 2026018900 21 DUPONT CIRCLE NW SUITE 300 WASHINGTON DC 20036 MICHAEL ROMANO SECRETARY/TREASURER 2.50 0.00 X X 0 0 0 LINGSHI TAN CHAIR 2.50 0.00 X X 0 0 0 JUDITH NG-CASHIN CHAIR ELECT 1.25 0.00 X X 0 0 0 KARIN VAN BAELEN MEMBER 1.25 0.00 X 0 0 0 MICHAEL DEVOY MEMBER 1.25 0.00 X 0 0 0 ELIZABETH GARNER MEMBER 1.25 0.00 X 0 0 0 ANGELIKA JOOS MEMBER 1.25 0.00 X 0 0 0 TATYANA KOSHELEVA MEMBER 1.25 0.00 X 0 0 0 MICHAEL ROSENBLATT MEMBER 1.25 0.00 X 0 0 0 JONATHAN SHELDON MEMBER 1.25 0.00 X 0 0 0 PETER SORGER MEMBER 1.25 0.00 X 0 0 0 KIHITO TAKAHASHI MEMBER 1.25 0.00 X 0 0 0 REBACCA VERMEULEN PAST CHAIR 2.50 0.00 X 0 0 0 CYNTHIA VERST MEMBER 1.25 0.00 X 0 0 0 BARBARA LOPEZ KUNZ GLOBAL CHIEF EXECUTIVE 40.00 0.00 X 753186 0 35207 JOY WHITLOW CHIEF FINANCIAL OFFICER (END 09/20) 40.00 0.00 X 247273 0 27159 WILLIAM ALLMAN CHIEF DIGITAL OFFICER 40.00 0.00 X 344929 0 35811 ROBIN WEINICK SVP/MANAGING DIR, AMERICAS 40.00 0.00 X 251450 0 19945 TIM HESS GLOBAL IT DIRECTOR 40.00 0.00 X 241649 0 14988 LINDA HEE JUNG KO ASSOCIATE DIR, BUS DEVELOPMENT 40.00 0.00 X 177909 0 29828 CATHY PERSIDIS ASSOCIATE DIR, EMEA OPERATIONS 40.00 0.00 X 180818 0 11518 ALEXANDER ELDRIDGE IT PROJECT MANAGER 40.00 0.00 X 160342 0 28052 OZGUR KARA ASSOC DIRECTOR, EMEA FINANCE 40.00 0.00 X 174999 0 13778 RANJINI PRITHVIRAJ GLOBAL ASSC DIR (END 12/20) 40.00 0.00 X 151198 0 18011 2683753 0 234297 25 0 1 0 FREEMAN DECORATING SVCS INC PO BOX 734596 DALLAS TX 753734596 AUDIO VISUAL SERVICES 510364 EGON ZEHNDER INTL INC 520 MADISON AVE 23RD FLOOR NEW YORK NY 10022 PROFESSIONAL FEES RECRUITMENT 448121 MARRIOT BUSINESS SERVICES PO BOX 402642 ATLANTA GA 303842642 HOTEL, F&B SERVICES 390926 SMITHBUCKLIN CORPORATION 8318 SOLUTIONS CENTER CHICAGO IL 606778003 DIA EVENT SERVICES 364550 MILES TECHNOLOGIES 100 MOUNT HOLLY BYPASS LUMBERTON NJ 08048 IT SUPPORT SERVICES 357982 17 MEETINGS AND WORKSHOPS 611710 9102135 9102135 TRAINING 611710 3167808 3167808 MEMBERSHIP DUES 900099 956759 956759 PUBLICATIONS 900004 407496 407496 13634198 198767 198767 3033547 2960718 72829 72829 72829 INSURANCE RECOVERY 900099 5000000 5000000 5000000 18905794 13226702 407496 5271596 220 220 1971597 1478698 492899 6344690 4758517 1586173 311428 233571 77857 596908 447681 149227 589103 441827 147276 173189 129892 43297 310369 232777 77592 81939 61454 20485 722961 542221 180740 215532 161649 53883 187923 140942 46981 458148 343611 114537 664771 498578 166193 86625 64969 21656 96851 72638 24213 18759 14069 4690 371077 278308 92769 101195 75896 25299 MEETING COSTS 3807693 2855770 951923 BANK FEE & NA ADMIN EXP 806641 604981 201660 TRAINING & E-LEARNING 731676 548757 182919 CONSULTING EXPENSES 203163 152372 50791 170396 127797 42599 19022854 14267195 4755659 0 0 0 4107970 8151662 0 0 586814 350919 0 0 0 0 0 0 0 0 940983 1118714 4201109 3418614 936963 782495 7914633 8145238 0 0 0 0 0 0 1036180 1189440 15523543 19738468 2647013 6109962 0 0 5438499 1692007 0 0 0 0 0 0 0 0 300000 3000000 0 1058372 8385512 11860341 X 7138031 7878127 7138031 7878127 15523543 19738468 X -117060 848948 8208 X 0 1 X 1 0 X 21572283 22171029 23320631 23618071 13634198 104316212 21572283 22171029 23320631 23618071 13634198 104316212 0 0 0 104316212 790575 792626 355266 296267 198767 2433501 55708 14871 42676 24410 5851 143516 846283 807497 397942 320677 204618 2577017 -31338 -74607 -105945 -26385 5000000 4973615 22387228 22903919 23692188 23938748 18838816 111760899 0.93340 0.97450 0.02310 0.02720 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2016 AMOUNT: $ 0. 2017 AMOUNT: $ 0. 2018 AMOUNT: $ -26,385. 2019 AMOUNT: $ 0. 2020 AMOUNT: $ 5,000,000. 0 500532 338853 161679 3263312 2689838 573474 437265 389923 47342 782495 DUE FROM AFFILIATES 1156329 TENANT SECURITY DEPOSITS 33111 1189440 REFUNDABLE ADVANCE 1058372 1058372 X PART X, LINE 2: ASC 740 (FIN48) FOOTNOTE THE ASSOCIATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. EUROPE (INCLUDING ICELAND & GREENLAND) 1 19 PROGRAM SERVICES MEETINGS & TRAININGS 3988559 SOUTH ASIA 4 22 PROGRAM SERVICES MEETINGS & TRAININGS 5397220 5 41 0 0 5 41 9385779 0 9385779 1 0 1 0 0 1 PART III ACCOUNTING METHOD: X X X X 0 0 0 0 0 0 0 1 0 BARBARA LOPEZ KUNZ GLOBAL CHIEF EXECUTIVE 577889 0 175297 0 0 0 17100 0 18107 0 788393 0 0 0 WILLIAM ALLMAN CHIEF DIGITAL OFFICER 284754 0 60175 0 0 0 17100 0 18711 0 380740 0 0 0 JOY WHITLOW CHIEF FINANCIAL OFFICER (END 09/20) 195937 0 29387 0 21949 0 13050 0 14109 0 274432 0 0 0 ROBIN WEINICK SVP/MANAGING DIR, AMERICAS 221450 0 30000 0 0 0 13313 0 6632 0 271395 0 0 0 TIM HESS GLOBAL IT DIRECTOR 206240 0 35409 0 0 0 12329 0 2659 0 256637 0 0 0 LINDA HEE JUNG KO ASSOCIATE DIR, BUS DEVELOPMENT 177909 0 0 0 0 0 4326 0 25502 0 207737 0 0 0 CATHY PERSIDIS ASSOCIATE DIR, EMEA OPERATIONS 170582 0 10236 0 0 0 11518 0 0 0 192336 0 0 0 OZGUR KARA ASSOC DIRECTOR, EMEA FINANCE 164937 0 10062 0 0 0 13778 0 0 0 188777 0 0 0 ALEXANDER ELDRIDGE IT PROJECT MANAGER 147907 0 12435 0 0 0 9124 0 18928 0 188394 0 0 0 RANJINI PRITHVIRAJ GLOBAL ASSC DIR (END 12/20) 140046 0 11152 0 0 0 8640 0 9371 0 169209 0 0 0 NON-FIXED PAYMENTS SCHEDULE J, PART I, LINE 7 CERTAIN EMPLOYEES ARE ELIGIBLE FOR DISCRETIONARY BONUSES CONTINGENT ON MEETING INDIVIDUAL PERFORMANCE METRICS DURING THE YEAR AND THE ORGANIZATION'S GOALS AS A WHOLE. BONUSES ARE CONSIDERED ALONG WITH OTHER COMPENSATION TO ENSURE THAT ALL COMPENSATION PAYMENTS ARE REASONABLE. FORM 990, PART I, LINE 1 AND PART III, LINE 1 DRUG INFORMATION ASSOCIATION, INC. ("DIA") FOSTERS INNOVATION TO IMPROVE HEALTH AND WELLBEING WORLDWIDE BY: - PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; - DELIVERING CUSTOMIZED LEARNING EXPERIENCES; - BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND - OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. FORM 990, PART III, LINE 4B PROGRAM SERVICE ACCOMPLISHMENT 2 IN 2020 DIA HELD MORE THAN 200 MEETINGS, WORKSHOPS AND TRAININGS WORLDWIDE, DIA ATTRACTED OVER 10,000 PARTICIPANTS TO MEETINGS, WORKSHOPS AND TRAININGS IN THE UNITED STATES, EUROPE, CHINA, JAPAN AND INDIA. IN ADDITION TO THESE EVENTS, THE DIA ANNUAL MEETING, THE LEADING GLOBAL CONFERENCE ON PHARMACEUTICAL INFORMATION AND EDUCATION, ATTRACTED OVER 1,729 PARTICIPANTS FROM THE US AND ACROSS THE WORLD THROUGH ITS VIRTUAL PLATFORM. THE ANNUAL DIA EUROPEAN ANNUAL MEETING, WHICH IS RECOGNIZED AS ONE OF THE PREMIER FORUMS FOR THE EXCHANGE OF INFORMATION IN THE EUROPEAN MEDICAL/PHARMACEUTICAL COMMUNITY, ATTRACTED OVER 1,000 PARTICIPANTS. THE JAPAN ANNUAL MEETING AND CHINA ANNUAL MEETING HAD 572 AND 2161 PARTICIPANTS RESPECTIVELY. FORM 990, PART III, LINE 4C PROGRAM SERVICE ACCOMPLISHMENT 3 LEARNING: WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS LEARNING OPPORTUNITIES IN ELECTRONIC FORMAT. IN 2020, DIA HAD 5,177 ELEARNERS INCLUDING BOTH INDIVIDUALS AND GROUPS. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS OR STOCKHOLDERS THE ORGANIZATION HAS MEMBERS WHO PAY DUES BUT HAVE NO OWNERSHIP INTEREST IN THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 REVIEW PROCESS IRS FORM 990 IS PREPARED AND REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM. A DRAFT IS THEN JOINTLY REVIEWED BY THE PRESIDENT & GLOBAL CHIEF EXECUTIVE, THE CFO AND THE BOARD TREASURER/FINANCE COMMITTEE CHAIR. AFTER THIS REVIEW AND APPROVAL, A COMPLETE COPY OF THE FORM 990 IS PROVIDED TO THE BOARD PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST POLICY MONITORING AND ENFORCEMENT PERIODICALLY, MANAGEMENT EVALUATES EXISTING PAID VENDOR RELATIONSHIPS FOR GOODS AND/OR SERVICES. THEY ASSESS THE PARTIES INVOLVED AND THE RELATIONSHIPS BETWEEN THEM AND DIA. WHERE CONFLICTS WITH STANDING POLICY MAY DEVELOP OR EXIST, APPROPRIATE CORRECTIVE ACTIONS ARE TAKEN, UP TO AND INCLUDING REPLACEMENT OF THE VENDOR WITH A SUITABLE AND QUALIFIED SUBSTITUTE THAT POSES NO CONFLICT OF INTEREST. NEW VENDORS ARE EVALUATED TO DETERMINE IF POTENTIAL CONFLICTS EXIST BEFORE APPROVAL OF ANY PAID RELATIONSHIP IS GRANTED. EVERY YEAR, ALL BOARD MEMBERS COMPLETE AND SIGN A CONFIDENTIALITY AGREEMENT TO MAINTAIN CONFLICT OF INTEREST POLICY. IF A BOARD MEMBER IS CONFLICTED OR THERE IS A POTENTIAL PERCEIVED CONFLICT, THAT BOARD MEMBER WILL RECUSE THEMSELVES FROM FURTHER DELIBERATIONS AND DECISION-MAKING ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 PROCESS USED TO DETERMINE EXECUTIVE COMPENSATION ON A REGULAR BASIS, BUT NO LESS THAN BIENNIALLY, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE COMPLETE COMPENSATION PACKAGES OF ALL UPPER MANAGEMENT LEVEL EMPLOYEES TO ENSURE THEY ARE COMPLIANT WITH ALL APPLICABLE LAWS AND CONSISTENT WITH THE PROVISIONS OF STANDING COMPENSATION POLICY. THIS INCLUDES SALARY, BENEFITS, BONUSES AND OTHER PAYMENTS MADE TO BOTH SENIOR MANAGEMENT AND ALL OTHERS DEEMED TO BE SUBJECT TO COMPENSATION REVIEW. THE COMPENSATION COMMITTEE OBTAINS AND RELIES UPON COMPARABLE DATA IN THE SAME OR SIMILAR COMMUNITIES FOR SIMILAR SERVICES. THE REVIEW PROCESS AND BASIS FOR COMPENSATION PACKAGES IS ADEQUATELY DOCUMENTED. THE RESULTS OF THE EVALUATION ARE PRESENTED TO THE BOARD OF DIRECTORS IN A PERFORMANCE AND COMPENSATION REPORT. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART XI, LINE 9: FOREIGN CURRENCY EXCHANGE LOSS 8,208. DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 DRUG EDUCATION PA 0 1325609 DIA INC DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 DRUG EDUCATION PA 10 449966 DIA INC DIA LEARNING LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 475438125 DRUG EDUCATION PA 1211531 1280505 DIA INC DIA(INDIA) PRIVATE LIMITED UNIT 250 TIMES SQUAREANDHERI EAST MUMBAI IN 400059 SCIENTIFIC ED IN DIA INC C 16997 34815 1.00000 1 DIA EUROPE GMBH KUECHENGASSE 16 POSTAFACH BASEL SZ 4002 SCIENTIFIC ED SZ DIA INC C 16125 182595 1.00000 1 DIA E-LEARNING EUROPE GMBH KUECHENGASSE 16 POSTAFACH BASEL SZ 4002 SCIENTIFIC ED SZ DIA INC C 969 9894 1.00000 1 DIA (BEIJING) HEALTHCARE INFORMATION GATEWAY PLAZA BEIJING CH SCIENTIFIC ED CH DIA GLOBAL HLTH C 3858580 1812748 1.00000 1 SH DIA JAPAN NIHONBASHI LIFE SCI BLDG 6F TOKYO JA SCIENTIFIC ED JA DIA LLC C 1223786 3969075 1.00000 1 DIA (SHANGHAI) HEALTHCARE INFORMATION SHANGHAI SHANGHAI CH SCIENTIFIC ED CH DIA GLOBAL HLTH C -2004 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0 1 1 DIA INDIA R 19160 CASH